Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVI-IBD: Oral vs IV Iron in IBD
NCT05581420Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2022
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ferrous fumarate in iron deficiency anemia (IDA) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Normalization of Hb concentration at 12 weeks. Status: unknown.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05581420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05581420.